Hypertension, proteinuria, and RAAS inhibition use in children with systemic lupus erythematosus: data from a multi-institutional pediatric learning health system

Year of Publication:

Categories of Publication:

Lay Abstract and Manuscript Citation:

Chang JC, Atkinson MA, Davies AG, Maltenfort M, Luna IY, Razzaghi H, Dharnidharka VR, Flynn JT, Smoyer WE, Mitsnefes MM, Dixon BP, Gluck CA, Scobell R, Bailey LC, Furth SL, Forrest CB, Denburg MR, Wenderfer SE. Hypertension, proteinuria, and RAAS inhibition use in children with systemic lupus erythematosus: Data from a multi-institutional pediatric learning health system. Lupus. 2025 Jul;34(8):832-843. doi: 10.1177/09612033251345201. Epub 2025 May 20. PMID: 40393065; PMCID: PMC12185231.

Find publication:

https://pmc.ncbi.nlm.nih.gov/articles/PMC12185231/

The lay abstract for this publication was generated using an AI model and reviewed by the lead author and the PEDSnet Engagement Core team.

Scroll to Top